Intrinsic Value of S&P & Nasdaq Contact Us

LadRx Corporation CYTR OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
32/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CYTR

LadRx Corporation (CYTR) and trades at $0.09. The 52-week range is 0.05-0.86.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-3.21.

The stock has a beta of 2.10, a last dividend of $10.4580, operates in the Healthcare sector.

Trading Data
Current Price$0.09
52-Week Range0.05-0.86
Volume942
Beta (1Y)2.10
Last Dividend$10.4580
Company
IPO Date1986-11-10
Employees3
CEOSteven Kriegsman
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2328286081
CUSIP232828608
Income (Latest Year)
EBITDA$-3.62B
Operating Income$-3.62B
Net Income$-1.59B
EPS$-3.21
EPS Diluted$-3.21
Shares Outstanding$495.09M
Balance Sheet (Latest Year)
Total Assets$839.51M
Current Assets$837.04M
Cash & ST Investments$759.74M
Total Liabilities$2.26B
Net Debt$-759.74M
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message